Comparison of fasting glucose and oral glucose tolerance testing to screen for diabetes mellitus in subjects on long-term glucocorticoid therapy
Not Applicable
Completed
- Conditions
- Risk of diabetes in subjects receiving long-term glucocorticoid therapyMetabolic and Endocrine - Diabetes
- Registration Number
- ACTRN12607000540415
- Lead Sponsor
- Repatriation General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Long-term glucocorticoid therapy (> 6 months)
Exclusion Criteria
Type 1 diabetes mellitus
Active inflammatory disease (defined as clinical evidence of active synovitis, elevated C-reactive protein (CRP) or recent intensification of immunosuppressive therapy)
Significant hepatic (AST or ALT > 3 times upper limit of normal) or renal (serum creatinine > 200µmol/L) dysfunction
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sensitivity of fasting glucose to determine diabetes[At the end of the 12 month study period.]
- Secondary Outcome Measures
Name Time Method Prevalence of diabetes[At the end of the 12 month study period.]